Genes (Jul 2020)

The Need for Establishing a Universal CTG Sizing Method in Myotonic Dystrophy Type 1

  • Alfonsina Ballester-Lopez,
  • Ian Linares-Pardo,
  • Emma Koehorst,
  • Judit Núñez-Manchón,
  • Guillem Pintos-Morell,
  • Jaume Coll-Cantí,
  • Miriam Almendrote,
  • Giuseppe Lucente,
  • Andrea Arbex,
  • Jonathan J. Magaña,
  • Nadia M. Murillo-Melo,
  • Alejandro Lucia,
  • Darren G. Monckton,
  • Sarah A. Cumming,
  • Alba Ramos-Fransi,
  • Alicia Martínez-Piñeiro,
  • Gisela Nogales-Gadea

DOI
https://doi.org/10.3390/genes11070757
Journal volume & issue
Vol. 11, no. 7
p. 757

Abstract

Read online

The number of cytosine-thymine-guanine (CTG) repeats (‘CTG expansion size’) in the 3′untranslated region (UTR) region of the dystrophia myotonica-protein kinase (DMPK) gene is a hallmark of myotonic dystrophy type 1 (DM1), which has been related to age of disease onset and clinical severity. However, accurate determination of CTG expansion size is challenging due to its characteristic instability. We compared five different approaches (heat pulse extension polymerase chain reaction [PCR], long PCR-Southern blot [with three different primers sets—1, 2 and 3] and small pool [SP]-PCR) to estimate CTG expansion size in the progenitor allele as well as the most abundant CTG expansion size, in 15 patients with DM1. Our results indicated variability between the methods (although we found no overall differences between long PCR 1 and 2 and SP-PCR, respectively). While keeping in mind the limited sample size of our patient cohort, SP-PCR appeared as the most suitable technique, with an inverse significant correlation found between CTG expansion size of the progenitor allele, as determined by this method, and age of disease onset (r = −0.734, p = 0.016). Yet, in light of the variability of the results obtained with the different methods, we propose that an international agreement is needed to determine which is the most suitable method for assessing CTG expansion size in DM1.

Keywords